ConductScience.org, home

Paper · 36498571

References217

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118662538TGFbeta in Cancer.Cell2008https://conductscience.org/library/papers/18662538PubMed
229541713Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients.Food Funct2018https://conductscience.org/library/papers/29541713PubMed
329113986Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial.Clin Cancer Res2018https://conductscience.org/library/papers/29113986PubMed
428076844Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.Oncotarget2017https://conductscience.org/library/papers/28076844PubMed
520836077Retinoids regulate stem cell differentiation.J Cell Physiol2011https://conductscience.org/library/papers/20836077PubMed
628587207(-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway.Nutrients2017https://conductscience.org/library/papers/28587207PubMed
727919958Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.Anticancer Res2016https://conductscience.org/library/papers/27919958PubMed
834169240CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin.iScience2021https://conductscience.org/library/papers/34169240PubMed
923333149BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.Cell Stem Cell2013https://conductscience.org/library/papers/23333149PubMed
1017051156Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.Nature2006https://conductscience.org/library/papers/17051156PubMed
1123288916Chloroquine in cancer therapy: a double-edged sword of autophagy.Cancer Res2013https://conductscience.org/library/papers/23288916PubMed
1232816202Lurbinectedin: First Approval.Drugs2020https://conductscience.org/library/papers/32816202PubMed
1335505363Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells.Stem Cell Res Ther2022https://conductscience.org/library/papers/35505363PubMed
1434677457Recent Updates on Marine Cancer-Preventive Compounds.Mar Drugs2021https://conductscience.org/library/papers/34677457PubMed
1525138131Patent analysis as a tool for research planning: study on natural based therapeutics against cancer stem cells.Recent Pat Anticancer Drug Discov2015https://conductscience.org/library/papers/25138131PubMed
1632722234Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators.Molecules2020https://conductscience.org/library/papers/32722234PubMed
1720130650TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.Nature2010https://conductscience.org/library/papers/20130650PubMed
1818818525Dihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner.Autophagy2008https://conductscience.org/library/papers/18818525PubMed
1934439086Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy.Cancers (Basel)2021https://conductscience.org/library/papers/34439086PubMed
2033487592Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.Gut2021https://conductscience.org/library/papers/33487592PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/36498571/references